Novel Percutaneous Management of Giant Vegetations With Pulmonary Emboli
Journal of Cardiovascular Electrophysiology · 2026
DOI: 10.1111/jce.70183 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cardiovascular Electrophysiology, 2026. Verfasst von Jose Delgado Moreno und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Care, Mayo Clinic, Jacksonville, Florida, USA. Hauptthemen laut MEDLINE: Pulmonary Embolism, Device Removal, Prosthesis-Related Infections, Defibrillators, Implantable. Die Arbeit nennt 15 Literaturangaben. Gefördert von: The authors received no specific funding for this work..
Abstract (Originalsprache)
Background
Large vegetations in cardiac implantable electronic devices (CIEDs) are associated with high mortality due to risks of major pulmonary artery obstruction. The rising incidence of CIEDs infections has complicated management, particularly in patients with delayed diagnoses. Current guidelines recommend open‐heart surgery for vegetations > 2.5 cm, but this approach poses significant risks for high‐morbidity patients. This study evaluates the feasibility and outcomes of percutaneous vacuum‐assisted aspiration using the AngioVac system in managing giant vegetations (≥ 4.0 cm) in patients unsuitable for open surgery. Materials and Methods Fourteen patients with giant vegetations (≥ 4.0 cm), undergoing transvenous lead extraction, were treated with the AngioVac system. The procedure involved large‐bore central venous cannulation and extracorporeal aspiration of vegetations. Outcomes assessed included procedural success, embolization management, and post‐extraction microbiological findings.
Results
The cohort included 64% males with a median age of 73 years. Vegetation sizes ranged from 4.0 to ≥ 7.0 cm. Most patients (79%) presented with advanced heart failure symptoms (NYHA class III/IV). Despite pulmonary embolism in 29% of cases, all were successfully managed with mechanical aspiration. The procedure achieved 100% complete removal of all leads and vegetations, with no perioperative mortality, and all patients were discharged alive.
Conclusion
Percutaneous aspiration using the AngioVac system is a safe and effective alternative to open‐heart surgery for high‐risk patients with giant vegetations. This minimally invasive approach demonstrates potential for broader application in managing high‐risk CIEDs infections, warranting further investigation in larger studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Critical Care, Mayo Clinic, Jacksonville, Florida, USA.
- Department of Cardiac Surgery, Medical University of Vienna, Vienna, Austria.
- The Heart Institute at Palmetto General Hospital, Hialeah, Florida, USA.
ORCID-Profile: Jose Delgado Moreno, Cesar Khazen, Roger G Carrillo
Förderung
- The authors received no specific funding for this work.
Zitieren
APA
Moreno, J. D., Khazen, C., & Carrillo, R. G. (2026). Novel Percutaneous Management of Giant Vegetations With Pulmonary Emboli. Journal of Cardiovascular Electrophysiology. https://doi.org/10.1111/jce.70183
Vancouver
Moreno JD, Khazen C, Carrillo RG. Novel Percutaneous Management of Giant Vegetations With Pulmonary Emboli. Journal of Cardiovascular Electrophysiology. 2026. doi:10.1111/jce.70183
BibTeX
@article{Moreno2026,
author = {Moreno, Jose Delgado and Khazen, Cesar and Carrillo, Roger G},
title = {Novel Percutaneous Management of Giant Vegetations With Pulmonary Emboli},
journal = {Journal of Cardiovascular Electrophysiology},
year = {2026},
doi = {10.1111/jce.70183}
}
EUVIMED